tel +30 210 41 82 681
 





Genomedica is an diagnostic laboratory for Molecular Genetics and Cytogenetics. An extensive list of tests for heritable disorders is offered. Please browse under CLINICAL TESTS for more information.

 

05Preimplantation Genetic Diagnosis (PGD) – results in 12 hours

testPreimplantation Genetic Diagnosis (PGD) enables the screening of embryos for the possible presence of genetic conditions, such as Down syndrome, cystic fibrosis and sex-linked disorders, before implantation into the womb. Only healthy embryos are subsequently implanted.
24sure™ is a new technology that uses the principle of CGH arrays and molecular karyotyping to screen all 46 chromosomes for aneuploidies, i.e. loss or gain of a chromosome, and gross structural imbalance. The same method can be used to screen for the most common mutation in cystic fibrosis, ΔF508, and β-thalassaemia.  What does this test offer?
 

05Superscreen ™ - 21 syndromes


syndromeUsing a technique known as MLPA (Multiplex Ligation-dependent Probe Amplification), we screen for the 21 most common microdeletion/microduplication syndromes, such as DiGeorge, Prader-Willi/Angelman’s Williams, Smith-Magenis and others. Most of these syndromes cannot be detected by conventional microscopy and therefore will be missed by studying the G-banded karyotype alone.All the syndromes included in the Superscreen™ are associated with an abnormal phenotype and mental retardation.

24sure screen is used in conjunction with mutation screening for a rare genetic disorder at Genomedica in Greece

Genomedica, one of the largest private molecular biology and genetics laboratories in Greece, announced today that they have used BlueGnome’s 24sure platform to complete preimplantation genetic screening (PGS) for chromosomal aneuploidy following preimplantation genetic diagnosis (PGD) within the same, fresh cycle.
05Malignant Melanoma screen

melanomaMalignant melanoma occurs at a frequency of 15 to 20 per 100,000 individuals in the Western World. Although it is not the most common form of skin cancer, it accounts for almost 75% of all deaths caused by skin cancer because of it aggressive nature. The most significant factors affecting the occurrence of melanoma are exposure to UV rays (sunlight, protracted use of sunbeds) and the individual’s genetic pre-disposition.
 
The melanoma screen detects numerical changes in 3 loci on chromosomes 6 and 11 by Fluorescent In Situ Hybridization (FISH) and enables the differential diagnosis of melanoma vs. Spitz nevus, a benign skin cancer with a good prognosis.
 
   
05A life... to keep!

The cryopreservation of umbilical cord stem cells is a unique opportunity given to you on the most exciting moment of your life – the moment your child is born.The primary objective of ProCell is to communicate  to the public the true value of stem cell preservation, not only with regards to the current scientific criteria  based on today’s knowledge, but bearing in mind the potential for technological advance in the field of biotechnology and the promise of future possibilities.
 
Why is it important to store stem cells?

Superscreen ™ - 21 syndromes

Using a technique known as MLPA (Multiplex Ligation-dependent Probe Amplification), we screen for the 21 most common microdeletion/microduplication syndromes, such as DiGeorge, Prader-Willi/Angelman’s Williams, Smith-Magenis and others. Most of these syndromes cannot be detected by conventional microscopy and therefore will be missed by studying the G-banded karyotype alone.

 

All the syndromes included in the Superscreenare associated with an abnormal phenotype and mental retardation.

Read more

 
   
GreekEnglish (United Kingdom)

 

facebook, FACEBOOK  

 

 

 
Hosting & Design by MEDICAL PROMOTION